This is the property of the Daily Journal Corporation and fully protected by copyright. It is made available only to Daily Journal subscribers for personal or collaborative purposes and may not be distributed, reproduced, modified, stored or transferred without written permission. Please click "Reprint" to order presentation-ready copies to distribute to clients or use in commercial marketing materials or for permission to post on a website. and copyright (showing year of publication) at the bottom.
Subscribe to the Daily Journal for access to Daily Appellate Reports, Verdicts, Judicial Profiles and more...
Intellectual Property
Trade Secret Misappropriation
Tortious Interference With a Prospective Economic Advantage

Teva Pharmaceuticals USA Inc., Teva Canada Innovation G.P.-S.E.N.C. v. Health IQ LLC, Amgen Inc., Amgen USA Inc., Amgen Canada Inc., Amgen International Inc., Amgen (Europe) GMBH

Published: May 18, 2013 | Result Date: Apr. 29, 2013 | Filing Date: Jan. 1, 1900 |

Case number: 8:13-cv-00308-CJC-RNB Bench Decision –  Dismissal

To continue reading, please subscribe.
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!

Already a subscriber?

Enewsletter Sign-up